What is Lumedica Vision?
Lumedica Vision specializes in the development of advanced optical coherence tomography (OCT) hardware and artificial intelligence (AI) software solutions. Their flagship product, the OQ EyeScope 2.0, is designed to enhance diagnostic capabilities for eye care professionals and researchers. By integrating cutting-edge technology, Lumedica Vision aims to improve patient outcomes and advance the field of ophthalmology. The company is based in Durham, North Carolina, a hub for technological innovation.
How much funding has Lumedica Vision raised?
Lumedica Vision has raised a total of $296K across 2 funding rounds:
Debt
$146K
Debt
$150K
Debt (2021): $146K with participation from PPP
Debt (2025): $150K led by Centrust Bank
Key Investors in Lumedica Vision
PPP
Public-Private Partnership
Centrust Bank
Centrust Bank is a financial institution that provides various banking services, including debt financing, supporting the operational and growth needs of companies like Lumedica Vision.
What's next for Lumedica Vision?
With substantial backing and a focus on late-stage development, Lumedica Vision is poised for significant growth. The company's strategic investments will likely fuel further research and development, enabling the enhancement of their OQ EyeScope 2.0 and the exploration of new AI-driven diagnostic tools. This capital infusion is expected to accelerate market penetration and solidify Lumedica Vision's position as a leader in ophthalmic technology, driving innovation in eye care diagnostics.
See full Lumedica Vision company page
